Lineage Cell Therapeutics Earnings History image   This LCTX earnings history page last updated 5/3/2024
Lineage Cell Therapeutics Earnings History Chart
PeriodEarnings DateGAAP
Q4 20233/7/2024-0.030
Q3 202311/9/2023-0.040
Q2 20238/10/2023-0.030
Q1 20235/11/2023-0.030
Q4 20223/9/2023-0.030
Q3 202211/10/2022-0.040
Q2 20228/11/2022-0.040
Q1 20225/12/2022-0.040
Q4 20213/10/2022-0.170
Q3 202111/10/2021-0.050
Q2 20218/12/2021-0.030
Q1 20215/13/2021-0.010
Q4 20203/11/20210.010
Q3 202011/4/2020-0.050
Q2 20208/6/2020-0.040
Q1 20205/7/2020-0.060
Q4 20193/12/2020-0.030
Q3 201911/12/2019-0.110
Q2 20198/8/2019-0.200
Q1 20195/9/20190.300
Q4 20183/14/2019-0.36
Q3 201811/8/20180.53
Q2 20188/2/2018-0.03
Q1 20185/10/2018-0.5
Q4 20173/15/2018-0.58
Q3 201711/9/2017-0.08
Q2 20178/2/2017-0.11
Q1 20175/10/2017-0.08
Q4 20163/16/2017-0.05
Q3 201611/3/2016-0.09
Q2 20168/9/2016-0.11
Q1 20165/10/2016-0.19
Q4 20153/29/2016-0.13
Q3 201511/9/2015-0.18
Q2 20158/10/2015-0.12
Q1 20155/11/2015-0.13
Q4 20143/11/2015-0.14
Q3 201411/10/2014-0.12
Q2 20148/12/2014-0.16
Q1 20145/12/2014-0.14
Q4 20133/17/2014-0.35
Q3 201311/12/2013-0.16
Q2 20138/9/2013-0.14
Q1 20135/10/2013-0.15
Q4 20123/18/2013-0.12
Lineage Cell Therapeutics Revenue History Chart
PeriodEarnings DateGAAP
Q4 20233/7/20240.00B
Q3 202311/9/20230.00B
Q2 20238/10/20230.00B
Q1 20235/11/20230.00B
Q4 20223/9/20230.00B
Q3 202211/10/20220.00B
Q2 20228/11/20220.00B
Q1 20225/12/20220.01B
Q4 20213/10/20220.00B
Q3 202111/10/20210.00B
Q2 20218/12/20210.00B
Q1 20215/13/20210.00B
Q4 20203/11/20210.00B
Q3 202011/4/20200.00B
Q2 20208/6/20200.00B
Q1 20205/7/20200.00B
Q4 20193/12/20200.00B
Q3 201911/12/20190.00B
Q2 20198/8/20190.00B
Q1 20195/9/20190.00B
Q4 20183/14/20190.00B
Q3 201811/8/20180.00B
Q2 20188/2/20180.00B
Q1 20185/10/20180.00B
Q4 20173/15/20180.00B
Q3 201711/9/20170.00B
Q2 20178/2/20170.00B
Q1 20175/10/20170.00B
Q4 20163/16/20170.00B
Q3 201611/3/20160.00B
Q2 20168/9/20160.00B
Q1 20165/10/20160.00B
Q4 20153/29/20160.00B
Q3 201511/9/20150.00B
Q2 20158/10/20150.00B
Q1 20155/11/20150.00B
Q4 20143/11/20150.00B
Q3 201411/10/20140.00B
Q2 20148/12/20140.00B
Q1 20145/12/20140.00B
Q4 20133/17/20140.00B
Q3 201311/12/20130.00B
Q2 20138/9/20130.00B
Q1 20135/10/20130.00B
Q4 20123/18/20130.00B
Quotes delayed 20 minutes

Email EnvelopeFree LCTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Interface (TILE): 5/3/2024 5:00 AM
Corebridge Financial (CRBG): 5/3/2024 6:00 AM
Johnson Outdoors (JOUT): 5/3/2024 6:00 AM
City Office REIT (CIO): 5/3/2024 6:00 AM
Proto Labs (PRLB): 5/3/2024 6:00 AM
Amneal Pharmaceuticals (AMRX): 5/3/2024 6:00 AM
nVent Electric (NVT): 5/3/2024 6:30 AM
Chart Industries (GTLS): 5/3/2024 6:30 AM
Essent Group (ESNT): 5/3/2024 6:30 AM
AG Mortgage Investment (MITT): 5/3/2024 6:30 AM

More from the Next Earnings Dates Calendar

Earnings History:

Forum Energy Technologies (FET): 5/2/2024 6:37 PM
AES (AES): 5/2/2024 5:18 PM
Gold Resource (GORO): 5/2/2024 5:00 PM
Post Hldgs (POST): 5/2/2024 5:00 PM
Alliant Energy (LNT): 5/2/2024 5:00 PM
Ameren (AEE): 5/2/2024 5:00 PM
Consolidated Edison (ED): 5/2/2024 5:00 PM
Saul Centers (BFS): 5/2/2024 After close
Olympic Steel (ZEUS): 5/2/2024 After close
UMH Properties (UMH): 5/2/2024 After close

More from the Earnings History archive
On this page we presented the LCTX earnings and revenue history archive for Lineage Cell Therapeutics, comparing the historical top line revenue performance quarter by quarter, as well as the LCTX earnings per share history. Any self directed investor doing their due diligence on LCTX (or any other given stock) can benefit from researching all of the Lineage Cell Therapeutics past earnings and revenue results going backwards in time, and to help you with this Lineage Cell Therapeutics earnings history research, on this page we presented each quarter's resulting numbers in both table and graphical form for easy comparison. Studying these numbers can help an investor by providing important context with which to think about LCTX's next earnings report. In your continued research on Lineage Cell Therapeutics we hope you will be sure to check out the further links included for earnings surprises as well as next earnings dates for LCTX. Thanks for visiting, and the next time you need to research LCTX earnings history (or the earnings history of another stock), we hope you'll think of our site as your go-to earnings history research resource of choice.

Recommended: ATRC Price Target, Institutional Holders of GMM, Top Ten Hedge Funds Holding KNTE.

 

Lineage Cell Therapeutics Earnings History | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.